Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients

NCT06574984 · clinicaltrials.gov ↗

RECRUITING

Status

900

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Bleeding Disorder
Haemophilia A

Interventions

DRUG: Turoctocog alfa

Sponsor

Novo Nordisk A/S